Clinical Trials Logo

Clinical Trial Summary

At present, all commercially available corneal organ culture media contain foetal calf serum (FCS) and sometimes other compounds extracted from animals. These compounds are necessary for corneal cell survival but are problematic because they theoretically have risk of anthropozoonosis transmission, especially for new variant of CJD and the variability between FCS batches influence graft quality. Our laboratory research allowed in vitro and ex vivo validation of a new medium free compound animal. We proved its superiority over conventional medium containing 2% FCS for endothelial cell survival during the storage time. The goal of this clinical trial is now to assess its superiority in patients.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01694914
Study type Interventional
Source Centre Hospitalier Universitaire de Saint Etienne
Contact
Status Completed
Phase Phase 3
Start date January 2012
Completion date February 2014

See also
  Status Clinical Trial Phase
Recruiting NCT01206127 - DSAEK- Postoperative Positioning and Transplant Dislocation N/A
Terminated NCT00764582 - Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery Phase 4
Recruiting NCT05870566 - Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision] N/A
Recruiting NCT02084745 - Timing of Glaucoma Drainage Device With Boston Keratoprosthesis N/A
Unknown status NCT00834782 - Comparison of DCT, ORA and GAT in Eyes After Penetrating Keratoplasty Phase 4
Withdrawn NCT00345020 - Deep Lamellar Endothelial Keratoplasty: Small Incision Technique
Completed NCT00000137 - Collaborative Corneal Transplantation Studies (CCTS) Phase 3
Recruiting NCT04339907 - Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears) N/A
Active, not recruiting NCT00874835 - Corneal Endothelium Delivery Instrument Phase 2
Completed NCT00570648 - A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization N/A
Enrolling by invitation NCT03461978 - Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures N/A
Not yet recruiting NCT05210478 - Intraoperative Optical Coherence Tomography for Ophthalmic Surgical Guidance - Cornea
Completed NCT03381794 - The German Keratoplasty Registry of the German Ophthalmological Society (DOG) N/A
Recruiting NCT03105466 - Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea N/A
Completed NCT00409656 - Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients Phase 2
Recruiting NCT01018888 - Safety and Efficacy Study of Artificial Cornea Phase 4
Recruiting NCT04490902 - Clinical Study on the Treatment of Mixed Component Cornea for High Risk Keratoplasty N/A
Recruiting NCT04337944 - Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo) N/A
Completed NCT01547975 - Retrospective Analysis of Surgical Outcomes After Corneal Transplantation N/A
Terminated NCT00447642 - Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty Phase 3